OverviewSuggest Edit

DAXOR is a biotechnology company that provides original medical equipment for medical personnel. The Company manufactures the BVA-100 Blood Volume Analyzer, the first machine approved by the FDA that provides rapid direct measurement of a patient’s blood volume. 

TypePublic
Founded1970
HQNew York, US
Websitedaxor.com
Employee Ratings2.5

Latest Updates

Employees (est.) (Jun 2017)37
Share Price (Mar 2019)$12.5 (+2%)

Key People/Management at DAXOR

Michael Feldschuh

Michael Feldschuh

CEO and President
Jonathan Feldschuh

Jonathan Feldschuh

Chief Scientific Officer
Robert J. Michel

Robert J. Michel

CFO
Soren Thompson

Soren Thompson

Vice President Business Development
Kathryn A. Kornafel

Kathryn A. Kornafel

Vice President Marketing and Commercial Development
Show more

DAXOR Office Locations

DAXOR has an office in New York
New York, US (HQ)
350 5th Ave #4740
Show all (1)
Report incorrect company information

DAXOR Financials and Metrics

DAXOR Revenue

Market capitalization (22-Mar-2019)

46.8m

Closing stock price (22-Mar-2019)

12.5
DAXOR's current market capitalization is $46.8 m.
Show all financial metrics
Report incorrect company information

DAXOR Online and Social Media Presence

Embed Graph
Report incorrect company information

DAXOR News and Updates

Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019

NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that Michael Feldschuh, CEO, will be a featured presenter at the ROTH Capi…

Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today filed a Form N-CSR disclosing its schedule of portfolio holdings as of December 31, 20…

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress

New Research Abstracts Scheduled for Presentation on Daxor’s BVA-100®

Daxor Corporation Announces Acquisition of BVA-100® Blood Volume Analyzer to Aspirus Wausau Hospital in Wisconsin

NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Aspirus Wausau Hospital in Wausau Wisconsin has acquired a BVA-100 Bl…
Report incorrect company information

DAXOR Frequently Asked Questions

  • When was DAXOR founded?

    DAXOR was founded in 1970.

  • Who are DAXOR key executives?

    DAXOR's key executives are Michael Feldschuh, Jonathan Feldschuh and Robert J. Michel.

  • How many employees does DAXOR have?

    DAXOR has 37 employees.

  • Who are DAXOR competitors?

    Competitors of DAXOR include GenMark Diagnostics, Dadi and Abaxis.

  • Where is DAXOR headquarters?

    DAXOR headquarters is located at 350 5th Ave #4740, New York.

  • Where are DAXOR offices?

    DAXOR has an office in New York.

  • How many offices does DAXOR have?

    DAXOR has 1 office.